GLP-1/GIP Tirzepatide Tirzepatide is a prescription treatment used in programs focused on weight management and metabolic support for adults
By activating GLP-1 receptors in the brain, semaglutide may help restore balance to the reward system, making it easier for people to control cravings and reduce overeating
In real-life settings, people living with obesity and type 2 diabetes are at increased risks of cardiovascular disease, and these results suggest that initiating GLP-1RAs after bariatric surgery may help to achieve sustained reductions in weight and blood glucose levels comparable to those achieved by bariatric surgery alone in other patients and may also reduce the long-term risk for MACE.
Most patients receive their medication within 3 to 7 business days, though some reviews report faster delivery
$180 first month, $280/mo recurring (12-mo bundle) Compounded sema + tirz combo (Elite) $329 first month, $379/mo recurring (1-mo plan) Ozempic, Wegovy, Mounjaro, Zepbound Not offered INCLUDES Initial Lab Test Required and out of pocket